Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001972103 | SCV002209378 | uncertain significance | RYR1-related disorder | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 1 of the RYR1 gene. It does not directly change the encoded amino acid sequence of the RYR1 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV004010941 | SCV004824877 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-10-30 | criteria provided, single submitter | clinical testing | This variant causes a G to A nucleotide substitution at the -10 position of intron 1 of the RYR1 gene. Splice site prediction tools are inconclusive regarding the impact of this variant on RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RYR1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Athena Diagnostics | RCV004999556 | SCV005620607 | uncertain significance | not provided | 2024-08-09 | criteria provided, single submitter | clinical testing | |
Solve- |
RCV004770294 | SCV005091420 | likely pathogenic | King Denborough syndrome | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |